Microdosing means deliberately starting a peptide well below the usual standard or manufacturer dose, instead of jumping straight to the full recommended amount. The goal is not the fastest effect but first finding out how your own body reacts, then working up in small steps.

This page describes a risk-reduction principle - not a therapy, no specific amounts, and no substitute for medical advice. Concrete dosing belongs in professional hands.

What is microdosing?

The term currently comes mainly from the world of GLP-1 agonists (well-known weight-loss and diabetes drugs such as semaglutide or tirzepatide), but users also apply it to repair peptides like BPC-157 or TB-500. Important: microdosing is not an approved dosing mode, but an umbrella term from the user and telemedicine scene.

The principle: "start low, go slow"

Behind microdosing sits an old, well-established pharmacology principle: start low, go slow. You begin with a low amount, watch how you react, and only increase in small steps when needed and well tolerated. Working your way up in small steps is called titration.

Start low, below the usual starting amount.
Watch the reaction: tolerability, side effects, individual sensitivity.
Only increase after an adjustment phase and only in small steps.
Look for the lowest amount that gives the desired effect, rather than rushing to the top.

The clinical consensus is clear: side effects with these substances are typically dose-dependent and strongest in the first one to two weeks and after each increase. A slower ramp smooths exactly those peaks.

The safety guardrail: stay under the curve

In practice, microdosing often means step sizes and intervals deliberately differ from the manufacturer's instructions: smaller jumps, longer time on each step. The core guardrail: as long as you stay below or between the official dose steps and do not exceed the total amount intended for the duration of use, you are being more conservative, not more aggressive - slower and lower than intended, not faster or higher.

Honestly framed: that "slower and lower" lowers side effects is well documented. The exact rule "as long as the total summed over time is not exceeded, it is safe" is a reasonable, conservative rule of thumb - not a validated threshold and not a guarantee.

Why this can make sense for beginners

Test your individual reaction: people react very differently. A low start shows whether and how you respond before going "all in".
Minimise side effects: with GLP-1, nausea is the most common side effect, strongly dose-dependent and worst shortly after starting or increasing. A gentle start smooths this phase.
Keep control: small steps are easier to pause or walk back than a hard start at a high dose.
One variable at a time: for combinations, the community rule of thumb is to test one agent alone first, to attribute your reaction cleanly (community practice, not clinically validated).

The strongest evidence for the core idea: in a randomised semaglutide study, slower titration clearly lowered nausea and sharply reduced dropouts from gastrointestinal issues - at the same outcome. Starting gently can mean genuinely fewer problems at equal benefit.

Where is this done?

Microdosing is currently practised and marketed mainly in the US, driven by large telemedicine providers, social media and a very large GLP-1 user base. A key driver is economic - critics openly point out it partly benefits the providers most.

Limits and caution

This belongs here honestly:

"Better tolerated" is documented, "effective at a mini-dose" is not. That slow and low lowers side effects is shown. That a permanently very low amount reliably delivers the desired effects is not - the benefit beyond tolerability is largely anecdotal.
For most research peptides (BPC-157, TB-500), solid human studies are missing. Cycles and "start low" schemes are community convention; the human safety profile is largely unknown.
Self-dosing is the real risk factor. Mistakes in mixing or converting - not just overdosing - cause real, serious incidents. This holds regardless of dose size.
No approval status. Sourcing, purity and quality outside regular channels are a separate risk.
Individual factors such as pre-existing conditions, interactions or sensitivity can only be judged with medical supervision.

And the calculator?

Since peptides usually come as a powder that must be dissolved in water before injecting: once you have decided - cautiously and low - on a certain amount, the injection calculator helps you convert it into units on the insulin syringe and the matching amount of water. If you accidentally used too much water and therefore very many units, the reverse-dose calculator shows what amount was really in one injection. Both tools only calculate - they give no dosing or use recommendation.

Signed in, you can record every mix and injection in the injection manager - which helps you keep track while working up slowly.

Read on: Reconstituting peptides · Calculating a peptide dose

Microdosing with peptides: start low, test your reaction